✦ LIBER ✦

Low dose erythropoietin-beta improves anemia and maintains ribavirin dose in chronic hepatitis C patients receiving combination therapy with ribavirin plus pegylated interferon Alfa-2b

✍ Scribed by Kuo-Chih Tseng; Li-Hsuan Chen; Chi-Yi Chen; Ting-Tsung Chang; An-Liang Chou; I-Chin Wu; Pin-Nan Cheng

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Once-weekly epoetin alfa improves anemia

✍ Douglas T Dieterich; Ronald Wasserman; Norbert Bräu; Tarek I Hassanein; Edmund J 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 213 KB

Indications and limitations for aged pat

✍ Tsugiko Oze; Naoki Hiramatsu; Takayuki Yakushijin; Kiyoshi Mochizuki; Masahide O 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 778 KB

Factors contributing to ribavirin dose r

✍ Shintaro Takaki; Akihito Tsubota; Tetsuya Hosaka; Norio Akuta; Takashi Someya; M 📂 Article 📅 2004 🏛 Springer Japan 🌐 English ⚖ 209 KB

r-interferon alfa–2b/ribavirin combined

✍ A. Perasso; G. Testino; F. Ansaldi; V. Venturino; G.C. Icardi 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 30 KB 👁 2 views

W1016 Efficacy and Safety of Erythropoie

✍ Purcell, Dagmary; Toro, Doris H. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 124 KB

Comparison between combination therapy w

✍ M. Capanni; M.R. Biagini; S. Nanni; E. Lorefice; M. Paci; M.C. Benini; E. Gai; A 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 111 KB